Beijing, China, March 22nd, 2007-Today, CapitalBio Corporation announced that CapitalBio BioMixer II Microarray Hybridization Station, an equipment developed independently by CapitalBio, had successfully passed the security and electromagnetic compatibility tests of the European Union CE accreditation, American FCC accreditation and Canadian ICE accreditation and obtained CE certificate, registration number: AE 50098997 0001, FCC certificate, registration number: AK 50098995 0001 and ICE certificate, registration number: AK 50099033 0001 respectively. The certificates indicate that this product has satisfied all technology standards and requirements of market admittance into the European Union and North American markets.
CapitalBio BioMixer II Microarray Hybridization Station uses proprietary technology of CapitalBio Corportation and has a high performance to price ratio. It helps the aqueous hybridization mixture spread evenly over the microarray surface by continuous 3-D rotation in an optimal condition. The rotational speed and temperature are continuous adjustable. This makes every individual sample spot react uniformly with the reaction reagent solution, resulting in enhanced reaction signal intensity and consistency. CapitalBio BioMixer II Microarray Hybridization Station is easy to operate, with up to 6 microarray slides hybridized simultaneously. It is the ideal tool for batch microarray hybridization reaction.